Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
fth
/
Faeth Therapeutics Ord Shs
FTH
Add to Watchlist
27.250
USD
+0.010
+0.04%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 08/03, 09:30 (ET)
36.52M
Market Cap
--
P/E TTM
Faeth Therapeutics Ord Shs
27.250
+0.010
+0.04%
Overview
Financials
Discussions
Analysis
Company
Profile
Overview
Financials
Discussions
Analysis
Company
Profile
More Details of Company
Faeth Therapeutics Ord Shs Info
Ticker Symbol
- -
Company name
- -
IPO date
- -
CEO
- -
Number of employees
- -
Security type
- -
Fiscal year-end
- -
Address
- -
City
- -
Stock exchange
- -
Country
- -
Postal code
- -
Phone
- -
Website
- -
Ticker Symbol
- -
IPO date
- -
CEO
- -
Company Executives of Faeth Therapeutics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Bob Holmen
Mr. Bob Holmen
Independent Director
Independent Director
1.28K
-0.08%
Mr. Josiah Craver
Mr. Josiah Craver
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
--
--
Mr. Christopher W. Gerry
Mr. Christopher W. Gerry
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Phillip B. Donenberg
Mr. Phillip B. Donenberg
Independent Director
Independent Director
--
--
Mr. Anand K. Parikh, J.D.
Mr. Anand K. Parikh, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Stephen M. Hahn, M.D.
Mr. Stephen M. Hahn, M.D.
Director
Director
--
--
Ms. Saira Ramasastry
Ms. Saira Ramasastry
Director
Director
--
--
Ms. Karen Vousden
Ms. Karen Vousden
Director
Director
--
--
Mr. Brian Stephenson, Ph.D.
Mr. Brian Stephenson, Ph.D.
Chief Financial Officer and Principal Financial Officer
Chief Financial Officer and Principal Financial Officer
--
--
Mr. Oliver Maddocks, Ph.D.
Mr. Oliver Maddocks, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Bob Holmen
Mr. Bob Holmen
Independent Director
Independent Director
1.28K
-0.08%
Mr. Josiah Craver
Mr. Josiah Craver
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
--
--
Mr. Christopher W. Gerry
Mr. Christopher W. Gerry
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Phillip B. Donenberg
Mr. Phillip B. Donenberg
Independent Director
Independent Director
--
--
Mr. Anand K. Parikh, J.D.
Mr. Anand K. Parikh, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Stephen M. Hahn, M.D.
Mr. Stephen M. Hahn, M.D.
Director
Director
--
--
FAQs
Who are the top five shareholders of Faeth Therapeutics Ord Shs?
The top five shareholders of Faeth Therapeutics Ord Shs are: Mr. Bob Holmen